Neumora Therapeutics Updates on Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder

Press/Media

Period	27 Jul 2023

Media coverage

Title	Neumora Therapeutics Updates on Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder
Media name/outlet	Professional Services Close-Up
Country/Territory	United States
Date	27/07/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=68T9-R211-JCRR-047P-00000-00
Persons	Sanjay Mathew